Coenen E, Raimondi S, Harbott J, Zimmermann M, Alonzo T, Auvrignon A, Beverloo B, Chang M, Creutzig U, Dworzak M, Forestier E, Gibson B, Hasle H, Harrison C, Heerema N, Kaspers G, Leszl A, Litvinko N, Lo Nigro L, Morimoto A, Perot C, Reinhardt D, Rubnitz J, Smith F, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Pieters R, Zwaan M, van den Heuvel-Eibrink M. Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11Q23/MLL-rearranged AML patients: Results of an international study.
In: Pediatric Blood & Cancer: 43rd Congress of the International Society of Paediatric Oncology (SIOP). 2011, Auckland, New Zealand: John Wiley & Sons, Inc.
